Genetic Testing: A New Dawn in Healthcare


In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.

The Role of Information Technology


A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.

Collaborative Efforts and Data Sharing


Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.

Integration with Electronic Health Records


Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.

Challenges and Future Trends


Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.

A New Era in Healthcare


Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
Kevin haas, chief technology officer at myriad genetics

About the Author


Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Housing Costs Surge: Navigating the 2024 Construction Material Price Hike

In an unexpected twist of economic fate, the construction industry finds itself grappling with a steep ascent in building material costs, a trend that began its climb at the dawn of 2024.

Texas High-Tech Sector Rebounds Post-Pandemic, Set for New Growth Trajectory

As the dust settles from the pandemic, Texas' high-tech sector is shaking off its post-pandemic slump and gearing up for a new growth trajectory.

Struggling Landlords Seek Relief Amid Rising Insurance Costs

In the ever-evolving landscape of commercial real estate, a new challenge has emerged, straining the resilience of landlords and developers alike. The soaring costs of insurance, exacerbated by climate-induced natural disasters, are creating a formidable obstacle for property owners. Particularly affected are coastal cities and towns, where the risk of storms and floods is high.

By |October 24, 2024|Categories: Article, Insurance, Real Estate|Tags: , |0 Comments

CDK Global’s Cyberattack Disrupts U.S. Car Dealerships

In a significant cyberattack that has disrupted operations across the United States, CDK Global, a leading provider of cloud-based software to automotive dealerships, was forced to shut down most of its systems. This incident has highlighted the vulnerabilities and rising trend of cyberattacks targeting the auto industry.

By |October 23, 2024|Categories: Article, Automotive Industry, Cybersecurity|Tags: , |0 Comments

Commercial Real Estate: A Sector Under Siege

The commercial real estate landscape has experienced seismic shifts, particularly with properties purchased prior to the Covid-19 pandemic. Many of these assets now hold diminished value compared to the loans used to acquire them.